128 related articles for article (PubMed ID: 29189239)
21. Solving lymphoma's stem-cell problem.
Arney K
Nature; 2018 Nov; 563(7731):S48-S49. PubMed ID: 30429564
[No Abstract] [Full Text] [Related]
22. [Application of ibrutinib in primary central nervous system lymphoma].
Pang DW; Chen FL; Li WY
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):348-350. PubMed ID: 32447944
[No Abstract] [Full Text] [Related]
23. First-in-class guanylate cyclase stimulator approved for PAH.
Guha M
Nat Biotechnol; 2013 Dec; 31(12):1064. PubMed ID: 24316627
[No Abstract] [Full Text] [Related]
24. Can we improve on ibrutinib in mantle cell lymphoma?
Rule S
Lancet Haematol; 2018 Mar; 5(3):e98-e99. PubMed ID: 29396093
[No Abstract] [Full Text] [Related]
25. ibrutinib (IMBRUVICA°) and Waldenström's macroglobulinaemia.
Prescrire Int; 2016 Oct; 25(175):232. PubMed ID: 30645823
[TBL] [Abstract][Full Text] [Related]
26. Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation.
Zhang Q; Chen J; Gao H; Zhang S; Zhao C; Zhou C; Wang C; Li Y; Cai Z; Mou L
Int J Med Sci; 2018; 15(11):1118-1128. PubMed ID: 30123049
[TBL] [Abstract][Full Text] [Related]
27. [Ibrutinib - new tool in hematologist hand, new challenges for internist].
Majcherek M; Dworacka M; Dworacki G
Wiad Lek; 2017; 70(1):92-95. PubMed ID: 28343201
[TBL] [Abstract][Full Text] [Related]
28. FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
de Claro RA; McGinn KM; Verdun N; Lee SL; Chiu HJ; Saber H; Brower ME; Chang CJ; Pfuma E; Habtemariam B; Bullock J; Wang Y; Nie L; Chen XH; Lu DR; Al-Hakim A; Kane RC; Kaminskas E; Justice R; Farrell AT; Pazdur R
Clin Cancer Res; 2015 Aug; 21(16):3586-90. PubMed ID: 26275952
[TBL] [Abstract][Full Text] [Related]
29. Ibrutinib--a new standard treatment for relapsed mantle cell lymphoma?
Martin P
Lancet; 2016 Feb; 387(10020):728-9. PubMed ID: 26673812
[No Abstract] [Full Text] [Related]
30. [Cryptococcal meningitis in the treatment of CLL with ibrutinib: a case report and literature review].
Zhang H; Zhang XH; Chen P; Li BZ
Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):428-430. PubMed ID: 32536143
[No Abstract] [Full Text] [Related]
31. 58th American Society of Hematology Annual Meeting.
Smith LL
Lancet Haematol; 2017 Jan; 4(1):e13-e14. PubMed ID: 28041582
[No Abstract] [Full Text] [Related]
32.
Gustine JN; Xu L; Tsakmaklis N; Demos MG; Kofides A; Chen JG; Liu X; Munshi M; Guerrera ML; Chan GG; Patterson CJ; Keezer A; Meid K; Dubeau T; Yang G; Hunter ZR; Treon SP; Castillo JJ
Blood Adv; 2019 Oct; 3(19):2800-2803. PubMed ID: 31570491
[No Abstract] [Full Text] [Related]
33. A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib.
Lee CS; Rattu MA; Kim SS
J Oncol Pharm Pract; 2016 Feb; 22(1):92-104. PubMed ID: 25425007
[TBL] [Abstract][Full Text] [Related]
34. MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.
Treon SP; Xu L; Hunter Z
N Engl J Med; 2015 Aug; 373(6):584-6. PubMed ID: 26244327
[No Abstract] [Full Text] [Related]
35. Ibrutinib for Chronic Lymphocytic Leukemia.
Ruchlemer R; Ben Ami R; Lachish T
N Engl J Med; 2016 Apr; 374(16):1593-4. PubMed ID: 27096597
[No Abstract] [Full Text] [Related]
36. Ibrutinib for Chronic Lymphocytic Leukemia.
Rigolin GM; Cavazzini F; Cuneo A
N Engl J Med; 2016 Apr; 374(16):1593. PubMed ID: 27096596
[No Abstract] [Full Text] [Related]
37. Ibrutinib for Chronic Lymphocytic Leukemia.
Sharman JP; Mato AR; Keating MJ
N Engl J Med; 2016 Apr; 374(16):1592-3. PubMed ID: 27096595
[No Abstract] [Full Text] [Related]
38. Ibrutinib for Chronic Lymphocytic Leukemia.
Burger JA; Styles L; Kipps TJ
N Engl J Med; 2016 Apr; 374(16):1594-5. PubMed ID: 27096594
[No Abstract] [Full Text] [Related]
39. Initial treatment of B-cell prolymphocytic leukemia with ibrutinib.
Moore J; Baran AM; Meacham PJ; Evans AG; Barr PM; Zent CS
Am J Hematol; 2020 May; 95(5):E108-E110. PubMed ID: 31951033
[No Abstract] [Full Text] [Related]
40. Ibrutinib promising in subtype of DLBCL.
Brower V
Lancet Oncol; 2015 Sep; 16(9):e428. PubMed ID: 26212869
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
